Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Joinn Laboratories (603127)
- 39.96
- +2.01+5.30%
Market Closed May 15 15:00 CST
29.94BMarket Cap60.45P/E (TTM)
41.75High37.80Low650.54KlotVolume38.12Open37.95Prev Close2.65BTurnover10.32%Turnover Ratio100.65P/E (Static)749.35MShares45.9552wk High3.50P/B25.19BFloat Cap15.6552wk Low41.75Limit Up630.35MShs Float92.21Historical High34.16Limit Down10.41%Range %1.42Historical Low0.03Dividend TTM40.71Avg Price309.77KlotAsk0.08%Div Yield TTM100Lot Size292.81KlotBid
Joinn Laboratories (603127) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 45.30%983.08M | -5.53%911.85M | -50.98%902.06M | -69.32%662.23M | -76.39%676.57M | -66.29%965.2M | -36.64%1.84B | -29.02%2.16B | -3.36%2.87B | -1.85%2.86B |
| Transactional financial assets | 1.06%1.51B | 23.08%1.72B | 13.96%1.58B | 22.46%1.5B | 238.28%1.5B | 273.94%1.4B | 463.99%1.38B | 472.67%1.23B | 93.19%441.96M | -8.60%373.35M |
| Notes receivable and accounts receivable | 0.14%198.94M | -9.82%196.59M | -27.00%166.86M | -10.69%187.03M | 2.87%198.67M | 2.40%218M | 38.48%228.56M | 23.31%209.42M | 7.23%193.12M | 0.60%212.89M |
| -Notes receivable | -22.39%15.33M | -58.02%15.46M | 18.85%18.45M | 296.98%27.88M | 494.50%19.76M | 435.92%36.84M | 65.84%15.52M | -3.37%7.02M | -62.62%3.32M | -43.60%6.87M |
| -Accounts receivable | 2.62%183.61M | -0.02%181.13M | -30.34%148.41M | -21.36%159.15M | -5.73%178.91M | -12.06%181.17M | 36.83%213.04M | 24.50%202.4M | 10.85%189.8M | 3.30%206.01M |
| Other receivables (including interest and dividends) | -41.33%4.79M | -31.52%5.81M | -39.39%6.85M | -47.82%7.29M | -53.79%8.17M | -26.24%8.49M | 30.29%11.31M | 65.10%13.96M | 129.01%17.68M | 51.59%11.51M |
| -Other receivable | ---- | ---- | ---- | -47.82%7.29M | ---- | -26.24%8.49M | ---- | 65.10%13.96M | ---- | 51.59%11.51M |
| Contractual assets | 11.27%116.52M | 11.41%135.92M | -10.57%90.53M | -14.21%93.23M | 2.50%104.72M | -4.07%122M | -8.50%101.23M | 3.62%108.67M | -7.18%102.16M | -1.02%127.17M |
| Advance payment | -17.87%54.6M | -47.45%33.42M | -70.33%27.7M | -75.76%24.05M | -33.85%66.47M | -42.26%63.6M | -34.28%93.37M | 42.19%99.24M | -25.98%100.48M | 196.36%110.15M |
| Inventories | 2.26%1.56B | -4.48%1.41B | -3.54%1.57B | -4.36%1.56B | -9.81%1.53B | -20.64%1.48B | -23.14%1.63B | -23.29%1.63B | -29.21%1.69B | -15.11%1.86B |
| Non-current assets due within one year | -37.71%585.7M | 8.46%791.57M | --914.5M | --1.19B | -38.37%940.29M | -52.41%729.85M | ---- | ---- | 6,990.59%1.53B | --1.53B |
| Other current assets | 9.64%49.77M | 14.40%56.5M | 21.44%55.29M | 24.63%53.84M | 51.70%45.4M | 80.14%49.39M | 54.89%45.53M | 75.58%43.2M | 12.13%29.93M | 16.05%27.41M |
| Total current assets | 0.07%5.07B | 4.59%5.26B | -0.39%5.31B | -3.88%5.28B | -27.36%5.06B | -29.36%5.03B | -26.41%5.33B | -5.00%5.49B | 14.86%6.97B | 20.13%7.12B |
| Non Current assets | ||||||||||
| Other equity investment | -11.05%80.94M | -11.05%80.94M | -43.07%91M | -43.07%91M | -43.07%91M | -43.07%91M | 0.71%159.84M | 0.71%159.84M | 0.71%159.84M | 0.71%159.84M |
| Other non-current financial assets | 3.36%652.19M | 2.40%639.99M | 19.93%736.42M | 11.17%683.83M | 7.29%631.01M | 6.33%624.97M | 15.43%614.03M | 20.32%615.11M | 20.92%588.13M | 20.96%587.78M |
| Long-term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13.09%18.97M | -13.58%19.53M |
| Fixed assets | ---- | ---- | ---- | 16.59%790.96M | ---- | 19.45%696.79M | ---- | 15.72%678.4M | ---- | -1.17%583.32M |
| Constru in process | ---- | ---- | ---- | -7.33%286.54M | ---- | 7.87%368.93M | ---- | -3.01%309.22M | ---- | 23.14%342.01M |
| Productive biological assets | 193.80%1.1B | 74.38%668.39M | -0.87%389.64M | -6.05%376.21M | -7.95%373.38M | -31.41%383.3M | -41.47%393.07M | -40.39%400.44M | -48.14%405.63M | -29.02%558.87M |
| Intangible assets | -5.04%279.84M | -4.51%285.05M | -1.56%289.49M | -2.72%290.55M | 2.00%294.69M | 2.10%298.51M | -0.06%294.06M | 0.34%298.68M | -2.27%288.93M | -2.39%292.38M |
| Goodwill | -60.94%53.84M | -60.38%54.69M | 1.40%136.44M | 0.45%137.46M | 1.17%137.84M | 1.49%138.04M | -2.40%134.56M | -1.37%136.85M | 3.25%136.24M | 1.70%136.01M |
| Long deferred expense | 9.70%66M | 10.77%69.85M | -1.33%66.39M | 3.28%70.15M | -16.99%60.17M | -15.80%63.06M | 58.34%67.28M | 49.17%67.92M | 59.68%72.48M | 66.75%74.89M |
| Deferred tax assets | 19.73%40.7M | 18.95%39.68M | -18.94%31.76M | -21.53%29.44M | 1.69%34M | 18.07%33.36M | 17.78%39.18M | 13.07%37.52M | 13.32%33.43M | -13.37%28.25M |
| Usufruct assets | -30.91%30.57M | -69.14%16.24M | -58.04%27.07M | -31.15%35.21M | -22.70%44.25M | -17.08%52.61M | -21.49%64.52M | -32.00%51.14M | -27.49%57.25M | -17.96%63.45M |
| Other non current assets | 0.35%1.63B | -5.99%1.52B | -3.68%1.38B | -0.79%1.4B | 2,329.50%1.62B | 2,642.70%1.61B | 1,473.44%1.43B | -10.52%1.41B | -95.70%66.79M | -96.14%58.86M |
| Total non current assets | 13.96%4.97B | 1.25%4.42B | 0.70%4.22B | 0.60%4.19B | 57.88%4.36B | 50.25%4.36B | 40.43%4.19B | -6.06%4.17B | -38.33%2.76B | -34.51%2.91B |
| Total assets | 6.50%10.04B | 3.04%9.68B | 0.09%9.53B | -1.94%9.47B | -3.17%9.42B | -6.29%9.4B | -6.91%9.53B | -5.46%9.66B | -7.72%9.73B | -3.25%10.03B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | 19.74%53.33M | 47.26%73.96M | 38.78%54.55M | -18.22%52.82M | 8.39%44.54M | 15.92%50.22M | -42.15%39.31M | 31.41%64.59M | -35.73%41.09M | -65.97%43.32M |
| -Accounts payable | 19.74%53.33M | 47.26%73.96M | 38.78%54.55M | -18.22%52.82M | 8.39%44.54M | 15.92%50.22M | -42.15%39.31M | 31.41%64.59M | -35.73%41.09M | -65.97%43.32M |
| Contract liabilities | 19.48%1.04B | 3.27%854.24M | -8.00%978.97M | -20.59%896.15M | -29.65%871.31M | -28.20%827.16M | -22.38%1.06B | -19.09%1.13B | -15.31%1.24B | -11.02%1.15B |
| Salaries payable | 0.16%64.03M | 13.77%117.61M | -14.03%70.94M | -11.10%78.18M | -12.39%63.93M | -3.01%103.37M | 0.90%82.52M | 2.84%87.93M | 2.32%72.97M | -15.17%106.58M |
| Taxs payable | 22.35%17.64M | -17.35%19.67M | 22.88%10.58M | -34.82%10.96M | -60.95%14.42M | -46.64%23.8M | -74.50%8.61M | -39.06%16.81M | 79.85%36.93M | -29.17%44.6M |
| Other payable (including interest and dividends) | -15.88%57.33M | 13.50%71.1M | 20.52%74.97M | -49.30%95.68M | -15.16%68.16M | -29.60%62.65M | -37.65%62.2M | -39.60%188.71M | -59.83%80.34M | -55.40%88.99M |
| -Dividend payable | ---- | ---- | ---- | -81.34%22.39M | ---- | ---- | ---- | -44.00%119.98M | ---- | ---- |
| -Other payable | ---- | ---- | ---- | 6.64%73.3M | ---- | -29.60%62.65M | ---- | -29.99%68.73M | ---- | -55.40%88.99M |
| Non current liabilities due within one year | -23.65%24.52M | -48.77%20.17M | -30.24%27M | 8.84%30.39M | 14.87%32.12M | 43.18%39.37M | 20.92%38.7M | 3.42%27.93M | -6.66%27.96M | -0.14%27.5M |
| Other current liabilities | 15.54%3.68M | -3.84%3.84M | 4.52%3.47M | -19.78%2.97M | -31.72%3.19M | -9.13%3.99M | -22.06%3.32M | -5.31%3.7M | -25.61%4.67M | -33.12%4.39M |
| Total current liabilities | 14.93%1.26B | 4.50%1.16B | -6.02%1.22B | -23.12%1.17B | -26.95%1.1B | -24.32%1.11B | -23.17%1.3B | -20.11%1.52B | -18.98%1.5B | -20.44%1.47B |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 15.36%135.19M | 4.22%121.81M | -15.43%112.7M | -10.96%114.23M | -9.55%117.19M | -28.01%116.88M | -21.22%133.26M | -21.42%128.28M | -32.74%129.57M | -13.76%162.34M |
| Long term deferred income | -11.40%70.53M | 7.09%72.74M | 7.24%74.65M | 8.85%76.85M | 10.78%79.61M | -8.82%67.92M | -9.44%69.62M | -9.72%70.6M | -9.32%71.86M | -7.67%74.49M |
| Lease liabilities | -40.58%12.48M | -93.41%1.42M | -86.16%4.54M | -64.86%10.18M | -40.91%21M | -48.48%21.6M | -41.63%32.77M | -45.78%28.96M | -37.83%35.53M | -26.30%41.92M |
| Total non current liabilities | 0.19%218.2M | -5.05%195.97M | -18.57%191.89M | -11.67%201.25M | -8.09%217.79M | -25.96%206.4M | -22.02%235.64M | -22.73%227.84M | -28.49%236.96M | -15.29%278.75M |
| Total liabilities | 12.49%1.48B | 3.01%1.36B | -7.95%1.41B | -21.63%1.37B | -24.38%1.32B | -24.58%1.32B | -22.99%1.53B | -20.46%1.75B | -20.42%1.74B | -19.66%1.75B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.02%749.35M | 0.00%749.48M | 0.00%749.48M | -0.05%749.48M | -0.05%749.48M | -0.05%749.48M | -0.05%749.48M | 39.99%749.89M | 39.99%749.89M | 39.99%749.89M |
| Capital reserve funds | -0.08%5.23B | 0.00%5.24B | -0.24%5.24B | -0.56%5.24B | -0.56%5.24B | -0.56%5.24B | -0.29%5.25B | -3.89%5.27B | -3.87%5.27B | -3.89%5.27B |
| Surplus reserve funds | 0.00%167.79M | 0.00%167.79M | 16.31%167.79M | 16.31%167.79M | 16.31%167.79M | 16.31%167.79M | 20.71%144.26M | 20.71%144.26M | 20.71%144.26M | 20.71%144.26M |
| Retained profit | 22.13%2.61B | 13.15%2.37B | 9.08%2.15B | 13.83%2.13B | 12.92%2.14B | -3.19%2.09B | -6.85%1.97B | -0.43%1.87B | -13.77%1.89B | 7.88%2.16B |
| Less:Treasury stock | -1.96%226.38M | 4.54%230.57M | 9.22%230.57M | 3.51%230.9M | 43.18%230.9M | 50.61%220.56M | 68.22%211.1M | 104.88%223.06M | 150.46%161.26M | 175.52%146.45M |
| Other composite income | -51.53%23.61M | -38.98%30.19M | -55.05%43M | -54.47%47.14M | -51.95%48.71M | -50.78%49.48M | -9.54%95.66M | -4.84%103.54M | 11.22%101.38M | 5.19%100.52M |
| Shareholders equity without minority interests | 5.52%8.56B | 3.05%8.32B | 1.48%8.12B | 2.38%8.1B | 1.45%8.11B | -2.42%8.08B | -2.82%8B | -1.27%7.92B | -4.33%7.99B | 1.17%8.28B |
| Minority interests | -1.01%365.91K | 0.40%371.15K | 103.19%369.65K | 147.94%369.64K | -36.66%369.64K | -78.57%369.67K | -301.29%-11.6M | -112.75%-770.98K | -91.80%583.56K | -75.93%1.72M |
| Total shareholder equity | 5.52%8.56B | 3.05%8.33B | 1.63%8.12B | 2.40%8.11B | 1.44%8.11B | -2.44%8.08B | -3.03%7.99B | -1.36%7.92B | -4.41%7.99B | 1.10%8.28B |
| Total liabilityies and equity | 6.50%10.04B | 3.04%9.68B | 0.09%9.53B | -1.94%9.47B | -3.17%9.42B | -6.29%9.4B | -6.91%9.53B | -5.46%9.66B | -7.72%9.73B | -3.25%10.03B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm